Drug Side Effects
Search
CUTANEOUS T-CELL LYMPHOMA STAGE II
CUTANEOUS T-CELL LYMPHOMA STAGE II
was reported 22 times
CUTANEOUS T-CELL LYMPHOMA STAGE II is most prevalent among patients taking these drugs:
#
Drug
Count
Frequency
0
BEXAROTENE
2
0.0015
1
ROMIDEPSIN
1
0.0006
2
MECHLORETHAMINE HYDROCHLORIDE
1
0.0004
3
ACITRETIN
2
0.0004
4
DASPONE
2
0.0002
5
DAPSONE GEL, 5%
2
0.0002
6
DAPSONE
2
0.0002
7
FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%
1
0.0002
8
BRENTUXIMAB VEDOTIN
1
0.0001
9
CLOBETASOL PROPIONATE OINTMENT USP, 0.05%
1
0.0001
10
CLOBETASOL PROPIONATE
1
0.0001
11
IXEKIZUMAB
3
0.0001
12
ADALIMUMAB-FKJP
3
0.0001
13
ADALIMUMAB-AATY
3
0.0001
14
ADALIMUMAB-ADAZ
3
0.0001
15
TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%
1
0.0000
16
MYCOPHENOLATE MOFETIL
5
0.0000
17
VINCRISTINE SULFATE
1
0.0000
18
THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE
1
0.0000
19
TRIAMCINOLONE ACETONIDE
1
0.0000
20
UPADACITINIB
2
0.0000
21
LIRAGLUTIDE
1
0.0000
22
CYCLOSPORINE
2
0.0000
23
METHOTREXATE SODIUM
8
0.0000
24
TACROLIMUS OINTMENT 0.1%
2
0.0000
25
TACROLIMUS EXTENDED-RELEASE CAPSULES
2
0.0000
26
DUPILUMAB
8
0.0000
27
DOXYCYCLINE HYCLATE
1
0.0000
28
DOXYCYCLINE
1
0.0000
29
TACROLIMUS
2
0.0000
30
DOXORUBICIN
1
0.0000
31
GABAPENTIN
3
0.0000
32
FOLIC ACID
2
0.0000
33
ABATACEPT
1
0.0000
34
PREDNISONE
3
0.0000
35
CYCLOPHOSPHAMIDE FOR INJECTION
1
0.0000
36
CYCLOPHOSPHAMIDE
1
0.0000
37
RITUXIMAB
1
0.0000
38
ADALIMUMAB
3
0.0000
39
ETANERCEPT
1
0.0000